CoChat

Recent trends in molecular diagnostics of yeast infections: from PCR to NGS

Open access
Consortium OPATHY, Arastehfar, A, Boekhout, T, Butler, G, De Cesare, G Buda, Dolk, E, Gabaldón, T, Hafez, A, Hube, B, Hagen, F, Hovhannisyan, H, Iracane, E, Kostrzewa, M, Lackner, M, Lass-Flörl, C, Llorens, C, Mixão, V, Munro, C, Oliveira-Pacheco, J, Pekmezovic, M, Pérez-Hansen, A, Sanchez, A Rodriguez, Sauer, F M, Sparbier, K, Stavrou, A A, Vaneechoutte, M, Vatanshenassan, M, Gabaldón, Toni · 2019 · FEMS Microbiology Reviews
Cited by 131

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Abstract

The incidence of opportunistic yeast infections in humans has been increasing over recent years. These infections are difficult to treat and diagnose, in part due to the large number and broad diversity of species that can underlie the infection. In addition, resistance to one or several antifungal drugs in infecting strains is increasingly being reported, severely limiting therapeutic options and showcasing the need for rapid detection of the infecting agent and its drug susceptibility profile. Current methods for species and resistance identification lack satisfactory sensitivity and specificity, and often require prior culturing of the infecting agent, which delays diagnosis. Recently developed high-throughput technologies such as next generation sequencing or proteomics are opening completely new avenues for more sensitive, accurate and fast diagnosis of yeast pathogens. These approaches are the focus of intensive research, but translation into the clinics requires overcoming important challenges. In this review, we provide an overview of existing and recently emerged approaches that can be used in the identification of yeast pathogens and their drug resistance profiles. Throughout the text we highlight the advantages and disadvantages of each methodology and discuss the most promising developments in their path from bench to bedside.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/femsre/fuz015

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 131

Metadata

Authors
Consortium OPATHY, Arastehfar, A., Boekhout, T., Butler, G., De Cesare, G. B., Dolk, E., Gabaldón, T., Hafez, A., Hube, B., Hagen, F., Hovhannisyan, H., Iracane, E., Kostrzewa, M., Lackner, M., Lass-Flörl, C., Llorens, C., Mixão, V, Munro, C., Oliveira-Pacheco, J., Pekmezovic, M., Pérez-Hansen, A., Sanchez, A. R., Sauer, F. M., Sparbier, K., Stavrou, A. A., Vaneechoutte, M., Vatanshenassan, M., & Gabaldón, T.
Venue
FEMS Microbiology Reviews
Published
2019-06-03
Volume
43
Issue
5
Pages
517-547
ISSN
  • 0168-6445 (ISSN-L)
  • 1574-6976
OpenAlex
W2948495375
Cited by
131
References
50
FWCI
10.30
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.